IDiyas

For the Inventor, By the Inventor

Mont Saint Aignan, France

Lucette Duhamel

USPTO Granted Patents = 28


Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 223(Granted Patents)


Company Filing History:

goldMedal9 out of 20 
 
Societe Civile Bioprojet
 patents
silverMedal7 out of 40 
 
Rhone-poulenc Nutrition Animale
 patents
bronzeMedal4 out of 192 
 
Rhone-poulenc Sante
 patents
4. 2 out of 759 
 
Rhone-poulenc Chimie
 patents
5. 2 out of 1,743 
 
Institut National De La Sante Et De La Recherche Medicale
 patents
6. 2 out of 24 
 
Bioprojet
 patents
7. 2 out of 3 
 
Societe Civile Bioproject
 patents
8. 1 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 1988-2006

Loading Chart...
Loading Chart...
28 patents (USPTO):Explore Patents
1. 7094773 - [object Object] (2006-08-22),
2. 6878723 - LTA4 hydrolase inhibitors (2005-04-12),
3. 6835851 - Process for synthesizing N-(mercaptoacyl) amino acid derivatives from alpha-substituted acrylic acids (2004-12-28),
4. 6436973 - LTA4 hydrolase inhibitors (2002-08-20),
5. 6013829 - Process for the asymmetric synthesis of S-acyl derivatives of (2000-01-11),
6. 5945548 - Process for the synthesis of .alpha.-substituted acrylic acids and their (1999-08-31),
7. 5817890 - Process for preparation of halogenated or pseudohalogenated cyclic (1998-10-06),
8. 5786494 - Process for the synthesis of .alpha.-substituted acrylic acids and their (1998-07-28),
9. 5670531 - Amino acid derivatives, the process for their preparation and their (1997-09-23),
10. 5646313 - Amino acid derivatives, processes for their preparation and their (1997-07-08),
11. 5612371 - Amino acid, derivatives, processes for their preparation and their (1997-03-18),
12. 5599951 - Amino acid derivatives, the process for their preparation and their (1997-02-04),
13. 5449844 - Intermediates for preparing vitamins A and E and carotenoids (1995-09-12),
14. 5424460 - Synthesis intermediates containing a hexane ring and processes for their (1995-06-13),
15. 5331008 - Thioester enantiomeric compounds and their therapeutic uses (1994-07-19),

Lucette Duhamel: A Pioneer in Anti-Inflammatory Medicament Innovations

Introduction

Lucette Duhamel is a prominent inventor located in Mont Saint Aignan, France, known for her significant contributions to the field of medicinal chemistry. With an impressive portfolio of 28 patents, her work has largely focused on developing compounds with anti-inflammatory properties, showcasing her dedication to advancing healthcare.

Latest Patents

Lucette Duhamel's recent patents include innovative compounds that serve as medicaments targeting inflammation. One key invention relates to compounds that inhibit leukotriene A (LTA), an enzyme responsible for the production of leukotriene LTB, a major pro-inflammatory mediator. This invention not only highlights the anti-inflammatory capabilities of these compounds but also explores their therapeutic applications and methods of preparation. Another notable patent involves LTA4 hydrolase inhibitors, which are designed to inhibit LTA hydrolase and have significant therapeutic applications in combating inflammation.

Career Highlights

Throughout her career, Lucette Duhamel has been associated with respected companies such as Société Civile Bioprojet and Rhône-Poulenc Nutrition Animale. These associations have facilitated her research and development endeavours, resulting in impactful innovations in the field of biochemistry.

Collaborations

Lucette Duhamel has collaborated with esteemed professionals including Pierre Duhamel and Denis Danvy. These partnerships have enabled her to enhance her research and bring forth groundbreaking inventions in anti-inflammatory medications, showcasing the power of teamwork in scientific advancements.

Conclusion

With her extensive experience and remarkable portfolio of patents, Lucette Duhamel continues to be a significant figure in medicinal innovation. Her work in developing anti-inflammatory compounds not only contributes to the pharmaceutical landscape but also exemplifies the influence of dedicated inventors in improving health outcomes globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…